These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 30571694)

  • 21. Genetic dissection reveals that Akt is the critical kinase downstream of LRRK2 to phosphorylate and inhibit FOXO1, and promotes neuron survival.
    Chuang CL; Lu YN; Wang HC; Chang HY
    Hum Mol Genet; 2014 Nov; 23(21):5649-58. PubMed ID: 24916379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The synaptic function of LRRK2.
    Lee S; Imai Y; Gehrke S; Liu S; Lu B
    Biochem Soc Trans; 2012 Oct; 40(5):1047-51. PubMed ID: 22988863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Parkinson disease gene LRRK2: evolutionary and structural insights.
    Marín I
    Mol Biol Evol; 2006 Dec; 23(12):2423-33. PubMed ID: 16966681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants.
    Verma M; Callio J; Otero PA; Sekler I; Wills ZP; Chu CT
    J Neurosci; 2017 Nov; 37(46):11151-11165. PubMed ID: 29038245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3ß.
    Lin CH; Tsai PI; Wu RM; Chien CT
    J Neurosci; 2010 Sep; 30(39):13138-49. PubMed ID: 20881132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Motor Impairments and Dopaminergic Defects Caused by Loss of Leucine-Rich Repeat Kinase Function in Mice.
    Huang G; Bloodgood DW; Kang J; Shahapal A; Chen P; Kaganovsky K; Kim JI; Ding JB; Shen J
    J Neurosci; 2022 Jun; 42(23):4755-4765. PubMed ID: 35534227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons.
    Schapansky J; Khasnavis S; DeAndrade MP; Nardozzi JD; Falkson SR; Boyd JD; Sanderson JB; Bartels T; Melrose HL; LaVoie MJ
    Neurobiol Dis; 2018 Mar; 111():26-35. PubMed ID: 29246723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau promotes neurodegeneration via DRP1 mislocalization in vivo.
    DuBoff B; Götz J; Feany MB
    Neuron; 2012 Aug; 75(4):618-32. PubMed ID: 22920254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of PP2A and S6 Kinase as Modifiers of Leucine-Rich Repeat Kinase-Induced Neurotoxicity.
    Sim JPL; Ziyin W; Basil AH; Lin S; Chen Z; Zhang C; Zeng L; Cai Y; Lim KL
    Neuromolecular Med; 2020 Jun; 22(2):218-226. PubMed ID: 31664682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LRRK2 Promotes Tau Accumulation, Aggregation and Release.
    Guerreiro PS; Gerhardt E; Lopes da Fonseca T; Bähr M; Outeiro TF; Eckermann K
    Mol Neurobiol; 2016 Jul; 53(5):3124-3135. PubMed ID: 26014385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein.
    Niu J; Yu M; Wang C; Xu Z
    J Neurochem; 2012 Aug; 122(3):650-8. PubMed ID: 22639965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.
    Fulga TA; Elson-Schwab I; Khurana V; Steinhilb ML; Spires TL; Hyman BT; Feany MB
    Nat Cell Biol; 2007 Feb; 9(2):139-48. PubMed ID: 17187063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LRRK2 kinase regulates synaptic morphology through distinct substrates at the presynaptic and postsynaptic compartments of the Drosophila neuromuscular junction.
    Lee S; Liu HP; Lin WY; Guo H; Lu B
    J Neurosci; 2010 Dec; 30(50):16959-69. PubMed ID: 21159966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mouse models for LRRK2 Parkinson's disease.
    Xu Q; Shenoy S; Li C
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S186-9. PubMed ID: 22166430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A direct interaction between leucine-rich repeat kinase 2 and specific β-tubulin isoforms regulates tubulin acetylation.
    Law BM; Spain VA; Leinster VH; Chia R; Beilina A; Cho HJ; Taymans JM; Urban MK; Sancho RM; Blanca Ramírez M; Biskup S; Baekelandt V; Cai H; Cookson MR; Berwick DC; Harvey K
    J Biol Chem; 2014 Jan; 289(2):895-908. PubMed ID: 24275654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical genetic approach identifies microtubule affinity-regulating kinase 1 as a leucine-rich repeat kinase 2 substrate.
    Krumova P; Reyniers L; Meyer M; Lobbestael E; Stauffer D; Gerrits B; Muller L; Hoving S; Kaupmann K; Voshol J; Fabbro D; Bauer A; Rovelli G; Taymans JM; Bouwmeester T; Baekelandt V
    FASEB J; 2015 Jul; 29(7):2980-92. PubMed ID: 25854701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AMP kinase activation mitigates dopaminergic dysfunction and mitochondrial abnormalities in Drosophila models of Parkinson's disease.
    Ng CH; Guan MS; Koh C; Ouyang X; Yu F; Tan EK; O'Neill SP; Zhang X; Chung J; Lim KL
    J Neurosci; 2012 Oct; 32(41):14311-7. PubMed ID: 23055502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designing antibodies against LRRK2-targeted tau epitopes.
    Hamm M; Ladd TB; Levites Y; Golde TE; Giasson BI; Lewis J
    PLoS One; 2018; 13(9):e0204367. PubMed ID: 30261006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1.
    Azkona G; López de Maturana R; Del Rio P; Sousa A; Vazquez N; Zubiarrain A; Jimenez-Blasco D; Bolaños JP; Morales B; Auburger G; Arbelo JM; Sánchez-Pernaute R
    Mol Neurobiol; 2018 Jan; 55(1):506-516. PubMed ID: 27975167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LRRK2(I2020T) functional genetic interactors that modify eye degeneration and dopaminergic cell loss in Drosophila.
    Marcogliese PC; Abuaish S; Kabbach G; Abdel-Messih E; Seang S; Li G; Slack RS; Haque ME; Venderova K; Park DS
    Hum Mol Genet; 2017 Apr; 26(7):1247-1257. PubMed ID: 28158614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.